← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:888 | 888 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1216 | 73271-1216-1 | Methionine; Choline Chloride; Cyanocobalamin; Inositol | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:888 | 888 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-145 | 82396-145-13 | Lorazepam | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:888 | 888 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:888 | 888 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:888 | 888 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Naltrexone | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:888 | 888 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1571 | 72934-1571-2 | Niacinamide; Spironolactone | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:888 | 888 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nicotinamide Adenine Dinucleotide | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:889 | 889 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-198 | 63037-198-01 | Morphine Sulfate | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:889 | 889 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Progesterone; Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:889 | 889 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:889 | 889 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-949 | 69374-949-05 | Lidocaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:889 | 889 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:889 | 889 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketoconazole | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:889 | 889 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:889 | 889 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4035 | 71286-4035-5 | Midazolam Hydrochloride | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:889 | 889 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5030 | 71266-5030-2 | Midazolam | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:889 | 889 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-052 | 73198-052-30 | Methionine; Cyanocobalamin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:889 | 889 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lysine | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:889 | 889 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1010 | 73013-1010-1 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:889 | 889 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Triamcinolone Acetonide | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:889 | 889 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6600 | 71300-6600-9 | Naltrexone Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:889 | 889 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2577 | 72934-2577-2 | Niacinamide; Tazarotene | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:889 | 889 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nicotinamide Adenine Dinucleotide | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:890 | 890 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8604 | 71266-8604-1 | Moxifloxacin HCl | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:890 | 890 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Progesterone; Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:890 | 890 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:890 | 890 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:890 | 890 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:890 | 890 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-022 | 79926-022-10 | Ketoconazole | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:890 | 890 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:890 | 890 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4035 | 71286-4035-2 | Midazolam Hydrochloride | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:890 | 890 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-5020 | 70214-5020-1 | Midazolam | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:890 | 890 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-052 | 73198-052-10 | Methionine; Cyanocobalamin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:890 | 890 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0401 | 72196-0401-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:890 | 890 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:890 | 890 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5416 | 72934-5416-2 | Mupirocin; Metronidazole | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:890 | 890 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6646 | 71300-6646-3 | Naltrexone Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:890 | 890 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1545 | 72934-1545-2 | Niacinamide; Tretinoin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:890 | 890 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2455 | 72627-2455-2 | Nicotinamide Adenine Dinucleotide | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:891 | 891 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-886 | 69194-886-01 | 886 PITT FENTANYL 10 MCG/ML SYRINGE | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:891 | 891 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Progesterone; Estradiol; 7-Keto-Dehydroepiandrosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:891 | 891 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:891 | 891 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:891 | 891 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:891 | 891 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6442 | 71300-6442-2 | Ketoprofen | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:891 | 891 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:891 | 891 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:891 | 891 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-925 | 71170-925-01 | Midazolam | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:891 | 891 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6420 | 72682-6420-3 | Methionine; Inositol; Choline Chloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:891 | 891 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0415 | 72196-0415-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:891 | 891 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-613 | 70092-613-79 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:891 | 891 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0407 | 71285-0407-1 | N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:891 | 891 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6646 | 71300-6646-9 | Naltrexone Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:891 | 891 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2546 | 72934-2546-2 | Niacinamide; Tretinoin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:891 | 891 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2454 | 72627-2454-2 | Nicotinamide Adenine Dinucleotide | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:892 | 892 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-269 | 70092-269-37 | Fent 2 mcg/mlBup 0.0625% PF 250ml NS IVB | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:892 | 892 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Progesterone; Estradiol; 7-Keto-Dehydroepiandrosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:892 | 892 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:892 | 892 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:892 | 892 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:892 | 892 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-123 | 69852-123-10 | Ketorolac Tromethamine | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:892 | 892 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lactic Acid | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:892 | 892 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6412 | 71266-6412-2 | Mitomycin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:892 | 892 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-401 | 73702-401-02 | Midazolam | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:892 | 892 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-2632 | 26436-2632-3 | Methionine; Inositol; Choline Chloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:892 | 892 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0430 | 72196-0430-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:892 | 892 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:892 | 892 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5558 | 26436-5558-5 | Nadide | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:892 | 892 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6600 | 71300-6600-3 | Naltrexone Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:892 | 892 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2564 | 72934-2564-4 | Niacinamide; Tretinoin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:892 | 892 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2454 | 72627-2454-3 | Nicotinamide Adenine Dinucleotide | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:893 | 893 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-269 | 70092-269-37 | Fent 2 mcg/mlBup 0.0625% PF 250ml NS IVB | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:893 | 893 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:893 | 893 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:893 | 893 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:893 | 893 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:893 | 893 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketorolac Tromethamine; Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:893 | 893 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Leflunomide | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:893 | 893 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:893 | 893 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:893 | 893 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5030 | 26436-5030-3 | Methionine; Inositol; Choline Chloride; Cyanocobalamin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:893 | 893 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0422 | 71285-0422-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:893 | 893 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1039 | 73013-1039-1 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:893 | 893 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5558 | 26436-5558-0 | Nadide | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:893 | 893 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6610 | 71300-6610-9 | Naltrexone Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:893 | 893 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2564 | 72934-2564-2 | Niacinamide; Tretinoin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:893 | 893 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 85933-005 | 85933-005-10 | Nicotinamide Adenine Dinucleotide | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:894 | 894 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5538 | 72934-5538-5 | Nobela | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:894 | 894 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:894 | 894 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:894 | 894 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:894 | 894 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-090 | 71449-090-42 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:894 | 894 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketorolac Tromethamine; Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:894 | 894 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0423 | 71285-0423-1 | Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate; Serine; Threonine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:894 | 894 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:894 | 894 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:894 | 894 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5156 | 26436-5156-1 | Methionine; Inositol; Choline Chloride; Methylcobalamin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:894 | 894 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0416 | 72196-0416-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:894 | 894 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-133 | 70092-133-43 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:894 | 894 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0724 | 26436-0724-9 | Naltrexone | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:894 | 894 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6647 | 71300-6647-3 | Naltrexone Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:894 | 894 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1564 | 72934-1564-2 | Niacinamide; Tretinoin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:894 | 894 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-501 | 82396-501-06 | Nicotinamide Adenine Dinucleotide | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:895 | 895 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6600 | 71300-6600-3 | Naltrexone HCl | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:895 | 895 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:895 | 895 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:895 | 895 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:895 | 895 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0217 | 72196-0217-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Calcium Chloride; Sodium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Dextrose Monohydrate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:895 | 895 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketorolac Tromethamine; Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:895 | 895 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Levocarnitine | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:895 | 895 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-520 | 70092-520-49 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:895 | 895 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4036 | 71286-4036-1 | Midazolam Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:895 | 895 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5156 | 26436-5156-3 | Methionine; Inositol; Choline Chloride; Methylcobalamin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:895 | 895 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0406 | 72196-0406-1 | Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:895 | 895 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:895 | 895 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5633 | 26436-5633-1 | Naltrexone Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:895 | 895 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6647 | 71300-6647-9 | Naltrexone Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:895 | 895 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2561 | 72934-2561-2 | Niacinamide; Tretinoin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:895 | 895 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-501 | 82396-501-10 | Nicotinamide Adenine Dinucleotide | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:896 | 896 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6600 | 71300-6600-9 | Naltrexone HCl | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:896 | 896 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5364 | 26436-5364-3 | Estriol; Testosterone; Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:896 | 896 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:896 | 896 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:896 | 896 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0211 | 72196-0211-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Sodium Chloride; Sodium Gluconate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:896 | 896 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8230 | 71266-8230-5 | Ketorolac Tromethamine; Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:896 | 896 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 80098-005 | 80098-005-01 | Lidocaine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:896 | 896 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-314 | 70092-314-75 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:896 | 896 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4035 | 71286-4035-2 | Midazolam Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:896 | 896 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5156 | 26436-5156-8 | Methionine; Inositol; Choline Chloride; Methylcobalamin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:896 | 896 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5080 | 26436-5080-3 | Lysine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:896 | 896 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1036 | 73013-1036-1 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:896 | 896 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6610 | 71300-6610-9 | Naltrexone Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:896 | 896 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5629 | 26436-5629-1 | Naltrexone Hydrochloride Dihydrate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:896 | 896 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2566 | 72934-2566-2 | Niacinamide; Tretinoin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:896 | 896 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-146 | 73702-146-61 | Nicotinamide Riboside Chloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:897 | 897 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-264 | 71170-264-25 | Vancomycin 1.25g added to 250mL of 0.9% Sodium Chloride | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:897 | 897 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estrone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:897 | 897 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:897 | 897 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:897 | 897 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0211 | 71285-0211-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Sodium Chloride; Sodium Gluconate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:897 | 897 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8230 | 71266-8230-1 | Ketorolac Tromethamine; Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:897 | 897 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 80098-016 | 80098-016-01 | Lidocaine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:897 | 897 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-133 | 70092-133-43 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:897 | 897 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4035 | 71286-4035-3 | Midazolam Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:897 | 897 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-310 | 70092-310-46 | Methohexital Sodium | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:897 | 897 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lysine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:897 | 897 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-132 | 70092-132-43 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:897 | 897 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6610 | 71300-6610-3 | Naltrexone Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:897 | 897 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6220 | 72682-6220-1 | Nandrolone Decanoate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:897 | 897 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2569 | 72934-2569-2 | Niacinamide; Tretinoin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:897 | 897 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 84325-560 | 84325-560-14 | Nicotinamide Riboside Chloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:898 | 898 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9170 | 71266-9170-5 | Fentanyl | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:898 | 898 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Famotidine | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:898 | 898 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:898 | 898 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:898 | 898 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Benzocaine | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:898 | 898 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8231 | 71266-8231-1 | Ketorolac Tromethamine; Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:898 | 898 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:898 | 898 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-125 | 70092-125-48 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:898 | 898 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-312 | 70092-312-75 | Midazolam Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:898 | 898 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6305 | 72682-6305-1 | Methylcobalamin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:898 | 898 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lysine Hydrochloride; Arginine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:898 | 898 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:898 | 898 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6647 | 71300-6647-3 | Naltrexone Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:898 | 898 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2107 | 72627-2107-3 | Nandrolone Decanoate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:898 | 898 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2567 | 72934-2567-2 | Niacinamide; Tretinoin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:898 | 898 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-177 | 73198-177-10 | Nicotinamide Riboside Chloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:899 | 899 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0104 | 60652-0104-1 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:899 | 899 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Famotidine | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:899 | 899 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:899 | 899 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:899 | 899 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Phenylephrine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:899 | 899 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8231 | 71266-8231-5 | Ketorolac Tromethamine; Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:899 | 899 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:899 | 899 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-130 | 70092-130-36 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:899 | 899 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-032 | 70092-032-50 | Midazolam Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:899 | 899 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6310 | 72682-6310-1 | Methylcobalamin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:899 | 899 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lysine Hydrochloride; Arginine Hydrochloride; Proline; Glutamine | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:899 | 899 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-517 | 70092-517-43 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:899 | 899 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6647 | 71300-6647-9 | Naltrexone Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:899 | 899 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:899 | 899 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2568 | 72934-2568-2 | Niacinamide; Tretinoin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:899 | 899 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-177 | 73198-177-05 | Nicotinamide Riboside Chloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:900 | 900 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73217-007 | 73217-007-10 | Tacrolimus 0.3% Ophth | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:900 | 900 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:900 | 900 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:900 | 900 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:900 | 900 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Prilocaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:900 | 900 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketorolac Tromethamine; Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:900 | 900 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-111 | 73702-111-15 | Lidocaine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:900 | 900 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:900 | 900 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-177 | 70092-177-35 | Midazolam Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:900 | 900 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-051 | 73198-051-10 | Methylcobalamin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:900 | 900 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2431 | 72627-2431-1 | Magnesium Chloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:900 | 900 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-16 | Morphine Sulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:900 | 900 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5629 | 26436-5629-1 | Naltrexone Hydrochloride Dihydrate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:900 | 900 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:900 | 900 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nicotinamide Adenine Dinucleotide | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:900 | 900 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-550 | 71170-550-25 | Norepinephrine | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:901 | 901 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0122 | 70168-0122-1 | Testo200mgCHOL | 2025-1 | valid | 0 | 2026-09-18 |